KLK3 and benign prostatic hyperplasia: MiR-106a/miR-130b and miR-106a/miR-223 ratios, alone or in combination, effectively discriminate between lPC and BPH patients (AUC: of 0.81, 0.77, and 0.84, respectively) with specificity higher than that of PSA [231].